SonoSite acquires LumenVu

SonoSite, a Bothell, Wash.-based developer of hand-carried ultrasound devices, has acquired LumenVu, a privately held, development-stage company based in Philadelphia. LumenVu has developed a patented technology to improve the accuracy of catheter placement.

LumenVu’s technology will provide a way to track the tip of the catheter as it advances through a vessel to ensure that it is placed in the right location, potentially eliminating the need to confirm the location with x-ray or fluoroscopy, SonoSite said.

According to SonoSite, the acquisition will strengthen its position in the vascular access market as well as add a recurring revenue stream via the disposable catheter guidance device. SonoSite expects to introduce products based on this technology in late 2008.

Terms of the agreement were not disclosed and the transaction is not expected to have a material effect on SonoSite’s 2007 financial results, the company said.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup